BIOMAT Database Logo BIOMAT Database Logo

Keratinocyte growth factor-2 stimulates P-glycoprotein expression and function in intestinal epithelial cells. 2013

Seema Saksena, and Shubha Priyamvada, and Anoop Kumar, and Maria Akhtar, and Vikas Soni, and Arivarasu Natarajan Anbazhagan, and Anas Alakkam, and Waddah A Alrefai, and Pradeep K Dudeja, and Ravinder K Gill
Section of Digestive Diseases and Nutrition, Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA. saksena@uic.edu

Intestinal P-glycoprotein (Pgp/multidrug resistance 1), encoded by the ATP-binding cassette B1 gene, is primarily involved in the transepithelial efflux of toxic metabolites and xenobiotics from the mucosa into the gut lumen. Reduced Pgp function and expression has been shown to be associated with intestinal inflammatory disorders. Keratinocyte growth factor-2 (KGF2) has emerged as a potential target for modulation of intestinal inflammation and maintenance of gut mucosal integrity. Whether KGF2 directly regulates Pgp in the human intestine is not known. Therefore, the present studies were undertaken to determine the modulation of Pgp by KGF2 using Caco-2 cells. Short-term treatment of Caco-2 cells with KGF2 (10 ng/ml, 1 h) increased Pgp activity (~2-fold, P < 0.05) as measured by verapamil-sensitive [(3)H]digoxin flux. This increase in Pgp function was associated with an increase in surface Pgp levels. The specific fibroblast growth factor receptor (FGFR) antagonist PD-161570 blocked the KGF2-mediated increase in Pgp activity. Inhibition of the mitogen-activated protein kinase (MAPK) pathway by PD-98059 attenuated the stimulatory effects of KGF2 on Pgp activity. Small-interfering RNA knockdown of Erk1/2 MAPK blocked the increase in surface Pgp levels by KGF2. Long-term treatment with KGF2 (10 ng/ml, 24 h) also significantly increased PgP activity, mRNA, protein expression, and promoter activity. The long-term effects of KGF2 on Pgp promoter activity were also blocked by the FGFR antagonist and mediated by the Erk1/2 MAPK pathway. In conclusion, our findings define the posttranslational and transcriptional mechanisms underlying stimulation of Pgp function and expression by KGF2 that may contribute to the beneficial effects of KGF2 in intestinal inflammatory disorders.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol
D014700 Verapamil A calcium channel blocker that is a class IV anti-arrhythmia agent. Iproveratril,Calan,Cordilox,Dexverapamil,Falicard,Finoptin,Isoptin,Isoptine,Izoptin,Lekoptin,Verapamil Hydrochloride,Hydrochloride, Verapamil

Related Publications

Seema Saksena, and Shubha Priyamvada, and Anoop Kumar, and Maria Akhtar, and Vikas Soni, and Arivarasu Natarajan Anbazhagan, and Anas Alakkam, and Waddah A Alrefai, and Pradeep K Dudeja, and Ravinder K Gill
Keratinocyte growth factor stimulates CLC-2 expression in primary fetal rat distal lung epithelial cells.
April 1999, American journal of respiratory cell and molecular biology,
Seema Saksena, and Shubha Priyamvada, and Anoop Kumar, and Maria Akhtar, and Vikas Soni, and Arivarasu Natarajan Anbazhagan, and Anas Alakkam, and Waddah A Alrefai, and Pradeep K Dudeja, and Ravinder K Gill
Induction of P-glycoprotein expression and function in human intestinal epithelial cells (T84).
October 2008, Biochemical pharmacology,
Seema Saksena, and Shubha Priyamvada, and Anoop Kumar, and Maria Akhtar, and Vikas Soni, and Arivarasu Natarajan Anbazhagan, and Anas Alakkam, and Waddah A Alrefai, and Pradeep K Dudeja, and Ravinder K Gill
Keratinocyte growth factor down-regulates expression of the sucrase-isomaltase gene in Caco-2 intestinal epithelial cells.
December 1998, The Journal of biological chemistry,
Seema Saksena, and Shubha Priyamvada, and Anoop Kumar, and Maria Akhtar, and Vikas Soni, and Arivarasu Natarajan Anbazhagan, and Anas Alakkam, and Waddah A Alrefai, and Pradeep K Dudeja, and Ravinder K Gill
MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells.
February 2013, Molecular pharmacology,
Seema Saksena, and Shubha Priyamvada, and Anoop Kumar, and Maria Akhtar, and Vikas Soni, and Arivarasu Natarajan Anbazhagan, and Anas Alakkam, and Waddah A Alrefai, and Pradeep K Dudeja, and Ravinder K Gill
Effects of dietary ingredients on function and expression of P-glycoprotein in human intestinal epithelial cells.
January 2010, Biological & pharmaceutical bulletin,
Seema Saksena, and Shubha Priyamvada, and Anoop Kumar, and Maria Akhtar, and Vikas Soni, and Arivarasu Natarajan Anbazhagan, and Anas Alakkam, and Waddah A Alrefai, and Pradeep K Dudeja, and Ravinder K Gill
Keratinocyte growth factor enhances barrier function without altering claudin expression in primary alveolar epithelial cells.
December 2010, American journal of physiology. Lung cellular and molecular physiology,
Seema Saksena, and Shubha Priyamvada, and Anoop Kumar, and Maria Akhtar, and Vikas Soni, and Arivarasu Natarajan Anbazhagan, and Anas Alakkam, and Waddah A Alrefai, and Pradeep K Dudeja, and Ravinder K Gill
Keratinocyte Growth Factor Stimulates Macrophage Inflammatory Protein 3α and Keratinocyte-derived Chemokine Secretion by Mouse Uterine Epithelial Cells.
September 2010, American journal of reproductive immunology (New York, N.Y. : 1989),
Seema Saksena, and Shubha Priyamvada, and Anoop Kumar, and Maria Akhtar, and Vikas Soni, and Arivarasu Natarajan Anbazhagan, and Anas Alakkam, and Waddah A Alrefai, and Pradeep K Dudeja, and Ravinder K Gill
Keratinocyte growth factor stimulates bronchial epithelial cell proliferation in vitro and in vivo.
October 1999, The American journal of physiology,
Seema Saksena, and Shubha Priyamvada, and Anoop Kumar, and Maria Akhtar, and Vikas Soni, and Arivarasu Natarajan Anbazhagan, and Anas Alakkam, and Waddah A Alrefai, and Pradeep K Dudeja, and Ravinder K Gill
Keratinocyte growth factor injected into female mouse neonates stimulates uterine and vaginal epithelial growth.
September 1998, Endocrinology,
Seema Saksena, and Shubha Priyamvada, and Anoop Kumar, and Maria Akhtar, and Vikas Soni, and Arivarasu Natarajan Anbazhagan, and Anas Alakkam, and Waddah A Alrefai, and Pradeep K Dudeja, and Ravinder K Gill
A serum factor after intestinal resection stimulates epidermal growth factor receptor signaling and proliferation in intestinal epithelial cells.
August 2002, Surgery,
Copied contents to your clipboard!